110 related articles for article (PubMed ID: 15829999)
1. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
J Hum Hypertens; 2005 Jul; 19(7):551-7. PubMed ID: 15829999
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Thromb Res; 2005; 115(4):277-85. PubMed ID: 15668187
[TBL] [Abstract][Full Text] [Related]
3. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Shouzu A; Urase F; Maeda Y
Platelets; 2009 Sep; 20(6):406-14. PubMed ID: 19658004
[TBL] [Abstract][Full Text] [Related]
4. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.
Nomura S; Kanazawa S; Fukuhara S
J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659
[TBL] [Abstract][Full Text] [Related]
5. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
[TBL] [Abstract][Full Text] [Related]
6. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Kimura Y; Omoto S; Shouzu A; Nishikawa M; Iwasaka T
J Hum Hypertens; 2007 Jan; 21(1):38-44. PubMed ID: 17051237
[TBL] [Abstract][Full Text] [Related]
7. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
8. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
[TBL] [Abstract][Full Text] [Related]
9. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE
Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
Hogue JC; Lamarche B; Tremblay AJ; Bergeron J; Gagné C; Couture P
Metabolism; 2008 Mar; 57(3):380-6. PubMed ID: 18249211
[TBL] [Abstract][Full Text] [Related]
11. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of atherosclerosis markers in salt-sensitive hypertension.
Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A
Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197
[TBL] [Abstract][Full Text] [Related]
15. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
[TBL] [Abstract][Full Text] [Related]
16. Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
Rachmani R; Levi Z; Zadok BS; Ravid M
Clin Pharmacol Ther; 2002 Sep; 72(3):302-7. PubMed ID: 12235451
[TBL] [Abstract][Full Text] [Related]
17. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.
Nomura S; Inami N; Kanazawa S; Iwasaka T; Fukuhara S
Stem Cells; 2004; 22(5):696-703. PubMed ID: 15342934
[TBL] [Abstract][Full Text] [Related]
18. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
19. Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Nomura S; Iishii K; Inami N; Kimura E; Urase F
Pathophysiol Haemost Thromb; 2007; 36(1):32-9. PubMed ID: 18332612
[TBL] [Abstract][Full Text] [Related]
20. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
Martina V; Masha A; Gigliardi VR; Brocato L; Manzato E; Berchio A; Massarenti P; Settanni F; Della Casa L; Bergamini S; Iannone A
Diabetes Care; 2008 May; 31(5):940-4. PubMed ID: 18268065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
